The culprit of mesalamine intolerance: case series and literature review

BACKGROUND: Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice. Most of adverse reactions are due to the active components, which may lead to step-up treatment, but excipients are sometimes regarded as the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Cheng, Quan, Runze, Hong, Fangjing, Zou, Kaifang, Yan, Wei, Fu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670194/
https://www.ncbi.nlm.nih.gov/pubmed/31366329
http://dx.doi.org/10.1186/s12876-019-1049-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670194/
https://www.ncbi.nlm.nih.gov/pubmed/31366329
http://dx.doi.org/10.1186/s12876-019-1049-2

Ejemplares similares